ISIS Facility, Rutherford Appleton Laboratory, STFC, Didcot, OXON, UK OX11 0QX.
Department of Physics & Astronomy, the University of Manchester, Manchester M13 9PL, UK.
J Colloid Interface Sci. 2022 Feb 15;608(Pt 1):405-415. doi: 10.1016/j.jcis.2021.09.098. Epub 2021 Sep 22.
Although surfactants have been widely used in skin care and other related applications, our knowledge about how surfactants interact with stratum corneum (SC) lipids remains limited. This work reports how surfactants interact with a lipid SC model by neutron diffraction and molecular dynamics (MD) simulations, focusing on examining the impact of surfactant molecular architecture. The surfactant-SC mixed membrane was constructed by an equimolar mixture of ceramide/cholesterol/fatty acids and surfactant at 1% molar ratio of total lipids. The arrangements of water and surfactant molecules in the membrane were obtained through neutron scattering length density (NSLD) profiles via contrast variation method, meanwhile, MD simulation clearly demonstrated the mechanism of hydration change in the surfactant-model SC mixed membrane. No drastic difference was detected in the repeating distance of the short periodicity phase (SPP) upon adding surfactants, however, it significantly enhanced the membrane hydration and reduced the amount of phase separated crystalline cholesterol, showing a strong dependence on surfactant chain length, branching and double bond. This work clearly demonstrates how surfactant architecture affects its interaction with the SC membrane, providing useful guidance for either choosing an existing surfactant or designing a new one for surfactant-based transdermal application.
尽管表面活性剂已被广泛应用于皮肤护理和其他相关领域,但我们对表面活性剂与角质层(SC)脂质相互作用的了解仍然有限。本工作通过中子衍射和分子动力学(MD)模拟报告了表面活性剂与脂质 SC 模型的相互作用,重点研究了表面活性剂分子结构的影响。通过对比变化法,从中子散射长度密度(NSLD)曲线获得了含有相等摩尔比神经酰胺/胆固醇/脂肪酸和表面活性剂的 1%总脂质摩尔比的混合膜中,水和表面活性剂分子的排列。同时,MD 模拟清楚地证明了在表面活性剂模型 SC 混合膜中水合作用变化的机制。添加表面活性剂后,短周期性相(SPP)的重复距离没有明显差异,但它显著增强了膜水合作用,减少了相分离结晶胆固醇的量,这表明其强烈依赖于表面活性剂的链长、支化和双键。这项工作清楚地表明了表面活性剂结构如何影响其与 SC 膜的相互作用,为基于表面活性剂的经皮应用选择现有表面活性剂或设计新的表面活性剂提供了有用的指导。